研究方向
(1)建立國際領先的代謝-蛋白多組學前沿技術,發現腫瘤、炎症等疾病狀態下紊亂的內源性代謝,闡明活性代謝物的靶標組,從中挖掘轉化靶點;
(2)發現臨床具有確切療效的天然藥物的靶標,闡明藥效機制,激發針對靶標的化合物設計和改造;
(3)設計全新的非天然胺基酸,定向修飾蛋白,研究新翻譯後修飾的功能;
(4)生物藥物的細胞藥代動力學研究,描述其活性形式及代謝過程,指導創新生物藥物的設計、最佳化及評價。
主要成就
迄今在國際權威期刊Nature Methods、Redox Biology、APSB、Analytical Chemistry、Mol Cell Proteomics等以一作/通訊共發表SCI文章30餘篇,並受邀成為Nature Commun、Mass Spectrom Rev、Anal Chem、Anal Chim Acta等SCI期刊的審稿人。代表性研究如下:
•Wan N, Wang N, Yu S, Zhang H, Tang S, Wang D, Lu W, Li H, D Delafield, Kong Y, Wang X, Shao C, Lv L, Wang G, Tan R, Wang N*, Hao H*, Ye H*. Cyclic immonium ion of lactyllysine reveals widespread lactylation in the human proteome. Nat Methods 19, 854–864 (2022). 挖掘乳醯化在人類蛋白組中的廣泛修飾譜(IF=47.99),中國藥科大學官網首頁推薦工作
•Shao C, Lu W, Du Y, Yan W, Bao Q, Tian Y, Wang G, Ye H*, Hao H*. Cytosolic ME1 integrated with mitochondrial IDH2 supports tumor growth and metastasis. Redox Biol. 2020; 36:101685. 抗腫瘤代謝雙靶標的發現(IF=11.799)
•Zhu Y‡, Wan N‡, Shan X, Deng G, Xu Q, Ye H*, Sun Y*. Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice. Acta Pharmaceutica Sinica B. 2021; 11(5):1200-1212 . 抗炎天然藥物靶標發現(IF=11.413)
•Sang H‡ , Liu Jl‡ , Zhou F, Zhang XF, Zhang JW, Liu YZ, Wang GJ*, Ye H*. Target-responsive subcellular catabolism analysis for early-stage antibody‒drug conjugates screening and assessment. Acta Pharmaceutica Sinica B. 2021; Doi: https://doi.org/10.1016/j.apsb. 2021.05.024. 抗體偶聯藥物評價新技術(IF=11.413)
•Tian Y‡, Wan N‡, Ding M, Shao C, Wang N, Bao QY, Lu WJ, Hu HY, Sun HY, Yang CX, Zhou K, Chen S, Wang GJ, Ye, H*, Hao, HP*. Chemoproteomics Maps Glycolytic Targetome in Cancer Cells. bioRxiv. 2020.11.18.387670.
•Lu G, Xu X, Li G, Sun H, Wang N, Zhu Y, Wan N, Shi Y, Wang G, Li L, Hao H*, Ye H*. Subresidue-Resolution Footprinting of Ligand-Protein Interactions by Carbene Chemistry and Ion Mobility-Mass Spectrometry. Anal Chem. 2020; 92(1):947-956. 結構質譜突破之亞殘基水平蛋白印跡技術(IF=6.986)
•Li Q‡, Cao L‡, Tian Y, Zhang P, Ding C, Lu W, Jia C, Shao C, Liu W, Wang D, Ye H*, Hao H*. Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming. Mol Cell Proteomics. 2018; 17(8):1531-1545. 腸道菌群代謝產物的靶標發現(IF=4.828)
•Ye H‡, Wang J‡, Tian Z, Ma F, Dowell J, Bremer Q, Lu G, Baldo B*, Li L*. Quantitative Mass Spectrometry Reveals Food Intake-Induced Neuropeptide Level Changes in Rat Brain: Functional Assessment of Selected Neuropeptides as Feeding Regulators. Mol Cell Proteomics. 2017; 16(11):1922-1937. 治療厭食症的功能神經肽發現(IF=5.236)
•Wang L‡, Ye H‡, Sun D, Meng T, Cao L, Wu M, Zhao M, Wang Y, Chen B, Xu X, Wang G*, Hao H*. Metabolic Pathway Extension Approach for Metabolomic Biomarker Identification. Anal Chem. 2017; 89(2):1229-1237. 基於質譜的全新結構代謝物發現(IF=6.042)
•Ye H, Gemperline E, Venkateshwaran M, Chen R, Delaux PM, Howes-Podoll M, Ané JM, Li L*. MALDI mass spectrometry-assisted molecular imaging of metabolites during nitrogen fixation in the Medicago truncatula-Sinorhizobium meliloti symbiosis. Plant J. 2013; 75(1):130-145. 質譜成像解密細菌-植物共生體系代謝物分布(IF=6.815)
獲獎記錄
1、江蘇省傑出青年基金獲得者
2、中國藥科大學興藥青創學者
3、江蘇省六大人才高峰
4、江蘇省科協青年人才托舉工程
5、江蘇省雙創博士
6、分析測試學會CAIA二等獎
社會任職
目前擔任中國藥理學會藥代動力學委員會青年委員、江蘇省藥理學會理事及青年委員會秘書長、國際女性質譜學者協會Females in MS (FeMS)聯絡委員會會長。